InvestorsHub Logo
Followers 43
Posts 866
Boards Moderated 0
Alias Born 03/08/2014

Re: longfellow95 post# 220785

Monday, 04/01/2019 9:31:04 AM

Monday, April 01, 2019 9:31:04 AM

Post# of 704410
I have a substantially large network. People who I know and who have invested in NWBO believe the trial has run long enough and all this vague talk about multi-month processes to get to data-lock and top line announcement is wearing thin. Expectations in November, 2018 were that the outside limit for top line would be ASCO 2019 and many were upset even at this date. ASCO is a very important event and certainly a reasonably expected venue for top line announcement even at theatre. If ASCO comes and goes, especially accompanied by silence, I am certain that there will be deep disappointment and frustration. This is a perfect opportunity for market manipulators to take all the more advantage and drive the price down. The chorus of "gee they have not announced anything and they continue with silence.....hmmmmmm....seems like something is rotten in Bethesda(with apologies to Denmark)" will hit a crescendo with little if any buying support from downtrodden retail longs. Indeed, there will be justified fears that the next opportunity may be SNO, but don't count on it, because early 2020 looks more likely given NWBO's history.

Missing an announcement at ASCO strengthens the perception that this could really go on past 2019. There is no question in my mind that the share price will not maintain the status quo but rather deteriorate rapidly especially due to malevolent market forces. ASCO is a watershed event. If missed, I have little doubt that the market will be unkind to NWBO notwithstanding the new guy in IR. But I suppose this does not matter to loooooooooooooong term investors. JMHO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News